140405-98-7 Usage
Description
1-(4-bromophenyl)-2-[5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazol-3-yl]sulfanylethanone is a complex organic molecule characterized by its unique structure. It features a bromophenyl group, a triazolylsulfanyl group, and multiple methoxy substituents. As a ketone, it contains a carbonyl group attached to a phenyl ring. The presence of triazole and sulfanyl groups in the molecule indicates potential biological activity, as these functional groups are often found in pharmaceutical compounds. 1-(4-bromophenyl)-2-[5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazol-3-yl]sulfanylethanone may hold promise in medicinal chemistry and drug development due to its structural features, although further research and testing are required to fully comprehend its properties and potential uses.
Uses
Used in Pharmaceutical Industry:
1-(4-bromophenyl)-2-[5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazol-3-yl]sulfanylethanone is used as a potential pharmaceutical compound for its possible biological activity. The presence of triazole and sulfanyl groups suggests that it may interact with biological targets, making it a candidate for further exploration in drug development.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1-(4-bromophenyl)-2-[5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazol-3-yl]sulfanylethanone is used as a subject of study to understand its potential interactions with biological systems. Its structural features may provide insights into the design of new drugs or the modification of existing ones.
Check Digit Verification of cas no
The CAS Registry Mumber 140405-98-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,0,4,0 and 5 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 140405-98:
(8*1)+(7*4)+(6*0)+(5*4)+(4*0)+(3*5)+(2*9)+(1*8)=97
97 % 10 = 7
So 140405-98-7 is a valid CAS Registry Number.
140405-98-7Relevant articles and documents
Synthesis and biological evaluation of thiazolo-triazole derivatives
Pignatello,Mazzone,Panico,Mazzone,Pennisi,Castana,Matera,Blandino
, p. 929 - 938 (2007/10/02)
Two series of isomeric thiazolo[3,2-b][1,2,4]triazole and thiazolo[2,3-c][1,2,4]triazole derivatives were prepared following multiple synthetic pathways. The obtained compounds were submitted to preliminar pharmacological assays to evaluate their anti-inf
